share on
- Quantinuum will bring its Helios quantum computer to Singapore and foster collaborations with local universities, startups, and industry partners across multiple sectors.
- Nelipak's newly opened Asia Pacific Technical Development Centre will streamline design and validation of sterile packaging for faster, region-wide product development.
- The goal of Global Innovation Labs's Singapore hub will be to identify, incubate, and scale startups in areas including AI, robotics, quantum, and sustainability.
Three companies have established new innovation hubs in Singapore on 11 March — Quantinuum, Nelipak, and Global Innovation Labs.
Quantum computing company, Quantinuum's new R&D and Operations Centre in Singapore will bring its Helios quantum computer to Singapore later this year. The facility will bring together company researchers, local universities, and industry partners to develop quantum applications across sectors such as pharmaceuticals, materials science, and finance.
The centre is also said to align with Singapore’s national push to grow quantum capabilities under its National Quantum Strategy, with support from the Singapore Economic Development Board (EDB) and collaboration with the Singapore National Quantum Office (NQO). Through the National Quantum Computing Hub, the National Quantum Strategy is developed and implemented by NQO, which is hosted in the Agency for Science, Technology and Research (A*STAR), and funded by the National Research Foundation (NRF).
In efforts to contribute to the local ecosystem and support innovation across the quantum value chain, Quantinuum is collaborating with pioneering startups in Singapore, including Entropica, which accesses Quantinuum systems through its Startup Partner Programme, and Squareroot8, with whom Quantinuum signed a Memorandum of Understanding to co-develop quantum communications applications.
Statements from various leaders on the expansion, are as follows:
Dr. Rajeeb Hazra, President and CEO, Quantinuum:
“We believe there are three pillars to a holistic strategy for building a sustainable quantum frontier: use cases, infrastructure, and workforce.
"Singapore provides an exceptional foundation for this approach, and we are proud to contribute our experience in ecosystem development as we build a leading quantum ecosystem together."
Dr. Marvin Lee, Country Leader, Quantinuum Singapore:
“The new Centre will enable local talent and industry to work hands-on with quantum technologies, co-develop solutions aligned with national priorities, and support high-value jobs.
"We are committed to building long-term capability and resilience in Singapore’s digital economy."
Josephine Teo, Minister for Digital Development and Information:
“Singapore aims to be a global hub for the development of algorithms and applications for quantum computers. We will tap on our strengths in sectors of potential application, such as finance, logistics, and pharmaceuticals.
"Doing so will not only benefit these industries in Singapore, but elsewhere in the world.”
Pee Beng Kong, Executive Vice President, EDB:
“Quantinuum’s expansion into Singapore marks an important step in translating quantum research into real-world industry applications.
"The Helios system and new R&D Centre will enable local companies and researchers to collaborate on next-generation solutions in areas such as drug discovery, materials innovation, and financial optimisation.
"This investment will deepen partnerships across our industry and research ecosystem and build high-value quantum capabilities from Singapore.”
In a similar update, Nelipak's new Asia-Pacific Technical Development Centre in Singapore aims to support medical device and pharmaceutical companies in developing sterile packaging solutions. The facility brings together the company’s regional technical development capabilities with its global packaging design and innovation network.
Nelipak cited Singapore’s role as a fast-growing hub for medical technology manufacturing and research as a key factor behind the investment, saying it allows the company to support customers across Southeast Asia, China, Japan, Korea, India, Australia, and New Zealand.
Designed with a goal to enhance how medical device and pharmaceutical companies develop and validate sterile packaging systems, the Asia-Pacific Technical Development Centre seeks to facilitate direct engagements between customers and Nelipak’s technical experts to co-develop and validate bespoke sterile barrier solutions, streamline iteration cycles and regulatory processes, and accelerate time to market.
Pat Chambliss, Chief Executive Officer of Nelipak shared his excitement on the opening of the centre, saying that it represents a foundational investment that supports its global customer base while anchoring Nelipak firmly in the Asia Pacific region.
Aldin Velic, Vice President and General Manager, Asia-Pacific, Nelipak, added that with medical device customers under immense pressure to move faster without compromising on safety, compliance, and performance, the centre allows customers to walk in with a device and a packaging challenge, and they leave with an engineered packaging solution, prototype samples in hand, and a clear path to development.
"We are replacing distance, delay, and fragmentation with expertise, speed, and collaboration.”
Soo Haw Yun, Vice President, Global Enterprises, EDB also shared his views, highlighting that the new centre will allow Nelipak to work closely with pharmaceutical and medical device companies in the region to accelerate product development and launches.
"The investment is a welcome addition to Singapore’s growing biomedical sciences ecosystem and strengthens our role as a regional hub for medtech innovation," he added.
Additionally, Global Innovation Labs (GIL), an external venture fund and global commercialisation initiative of research institute SRI International, has announced an investment and venture building hub in Singapore that will join GIL's existing hubs in the US South Korea, and Japan. It will focus on building deep-tech ventures in areas including next-generation hardware, sustainability, healthcare, robotics, quantum technologies, and artificial intelligence.
Supported by EDB, the initiative will draw on Singapore’s research base and academic institutions to support deep-tech founders and accelerate the commercialisation of intellectual property.
GIL is also exploring collaboration with the Agency for Science, Technology and Research to identify opportunities for venture creation based on research developed in Singapore.
David Park, General Partner, Global Innovation Labs said: “Through our collaboration with EDB and our strategic partnership with SRI, GIL Singapore represents the next evolution of venture building — where science, capital, and global commercialisation come together to create companies capable of leading on the world stage.”
Choo Heng Tong, Executive Vice President, EDB stated that GIL will strengthen Singapore’s leadership in turning scientific research into successful enterprises.
"By combining world-class IP from SRI and the research capabilities of our local academic and research institutions, we aim to build deep tech ventures that can scale from here and deliver long-term strategic value for Singapore.”
READ MORE: Yubico and TBWA\Singapore open regional hubs in Singapore
share on
